CTRI/2022/03/040769
Completed
Phase 2
Pre clinical and Clinical evaluation of the effect on oral administration of KARAPPAN CHOORANAM? along with external application of ERULI ENNAI? in the management of Pitha Karapan
Dr Rajeetha Miraaj0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
- Sponsor
- Dr Rajeetha Miraaj
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Frequent focusing for skin allergy
- •Severe itching in skin
- •Erythema in skin
- •Vesicles in skin
- •Oozing in skin
Exclusion Criteria
- •Children above 12 years
- •Children below 3 years
- •exacerbation of eczema
- •eczema associated with systemic illness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
KIRAMBU CHOORNAM IN SEIZURESCTRI/2022/03/040797Dr R Elamathi40
Completed
Phase 2
preclinical and clinical evaluation of the effect of siddha classical drug KANAI KIRUTHAM(oral administration)in the management of WHEEZING ASSOCIATED LOWER RESPIRATORY TRACT INFECTIOHealth Condition 1: J459- Other and unspecified asthmaCTRI/2022/02/039924Dr J Jayamani40
Completed
Phase 2
Preclinical and clinical evaluation of POONAI MEESAI CHOORANAM KUDINEER (Oral administration) in the management of NEPHROTIC SYNDROMEHealth Condition 1: N049- Nephrotic syndrome with unspecified morphologic changesCTRI/2022/03/040774Dr P Narmatha40
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of SINGATHI CHOORANAM along with external application of PEENASA THYLAMin the management of BACTERIAL SINUSITISin paediatric age group.CTRI/2022/10/046870Dr M Selvarathi
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of VAANI KIRUTHAM along with external application of VILVAPAZHA THYLUM with the procedure of SIRASU THAARAI in the management of ATTENTION DEFICIT HYPERACTIVITY DISORDER in paediatric age groupCTRI/2022/11/047018DR SUBBULAKSHMI S